SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-11-047955
Filing Date
2011-08-19
Accepted
2011-08-19 16:15:16
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a11-13893_410qa.htm 10-Q/A 84196
2 EX-10.2 a11-13893_4ex10d2.htm EX-10.2 392658
3 EX-10.6 a11-13893_4ex10d6.htm EX-10.6 97825
4 EX-31.3 a11-13893_4ex31d3.htm EX-31.3 7110
5 EX-31.4 a11-13893_4ex31d4.htm EX-31.4 6075
6 GRAPHIC g138934ki15i001.jpg GRAPHIC 5682
7 GRAPHIC g138934ki15i002.jpg GRAPHIC 2448
  Complete submission text file 0001104659-11-047955.txt   600260
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-19319 | Film No.: 111047651
SIC: 2834 Pharmaceutical Preparations